Product NDC: | 55566-5061 |
Proprietary Name: | Desmopressin Acetate |
Non Proprietary Name: | Desmopressin acetate |
Active Ingredient(s): | .2 mg/1 & nbsp; Desmopressin acetate |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 55566-5061 |
Labeler Name: | Ferring Pharmaceuticals Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA021795 |
Marketing Category: | NDA |
Start Marketing Date: | 20080505 |
Package NDC: | 55566-5061-1 |
Package Description: | 100 TABLET in 1 BOTTLE (55566-5061-1) |
NDC Code | 55566-5061-1 |
Proprietary Name | Desmopressin Acetate |
Package Description | 100 TABLET in 1 BOTTLE (55566-5061-1) |
Product NDC | 55566-5061 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Desmopressin acetate |
Dosage Form Name | TABLET |
Route Name | ORAL |
Start Marketing Date | 20080505 |
Marketing Category Name | NDA |
Labeler Name | Ferring Pharmaceuticals Inc. |
Substance Name | DESMOPRESSIN ACETATE |
Strength Number | .2 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Factor VIII Activator [EPC],Increased Coagulation Factor VIII Activity [PE],Increased Coagulation Factor VIII Concentration [PE],Vasopressin Analog [EPC],Vasopressins [Chemical/Ingredient] |